Impact of COVID-19 on Uro-Oncological Patients: A Comprehensive Review of the Literature

Abstract

Background: The aim of this paper is to discuss the impact of COVID-19 on patients with urological malignancies (prostate cancer, bladder and upper tract urothelial cancer, kidney cancer, penile and testicular cancer) and to review the available recommendations reported in the literature. Methods: A review was performed, through the PubMed database, regarding available recommendations reported in the literature, to identify studies examining the impact of COVID-19 on treatment and clinical outcomes (including upstaging, recurrence, and mortality) for uro-oncological patients. Results: The COVID-19 pandemic dramatically changed the urological guidelines and patients’ access to screening programs and follow-up visits. Great efforts were undertaken to guarantee treatments to high-risk patients although follow up was not always possible due to recurrent surges, and patients with lower risk cancers had to wait for therapies. Conclusions: Physically and mentally, uro-oncological patients paid a heavy price during the COVID-19 pandemic. Long term data on the “costs” of clinical decisions made during the COVID-19 pandemic are still to be revealed and analyzed.

A Real-World Retrospective Analysis of the Management of Advanced Urothelial Carcinoma in Canada

“…For example, provincial breast cancer screening programs were suspended for several months during the pandemic [32]. Also, in a review article concerning patients with urological malignancies, it was found that the pandemic dramatically affected patients' access to screening programs and follow-up visits [34]. A survey commissioned by the Canadian Cancer Survivor Network (CCSN) found that 54% had their cancer-care appointments canceled, postponed, or rescheduled because of COVID-19.…”

Assessing Trifecta and Pentafecta Success Rates between Robot-Assisted vs. Open Radical Cystectomy: A Propensity Score-Matched Analysis

“…This discrepancy likely derived from the limited availability of robotic surgical slots at our institution. Additionally, the COVID-19 pandemic may have exacerbated this issue by reducing the number of robotic procedures performed, thereby impacting surgical waiting lists adversely [34,35].…”

Prevalence and Antimicrobial Resistance Patterns of Hospital Acquired Infections through the COVID-19 Pandemic: Real-Word Data from a Tertiary Urological Centre

“…The implementation of COVID-19 protocols in our department did not appear to affect the AMR and MDRO rates. Nevertheless, the existing literature suggests that MDRO frequency increased during the COVID-19 pandemic, particularly for carbapenem-resistant Klebsiella pneumoniae, VRE and MRSA particularly in ICUs [18,[33][34][35]. This knowledge gap necessitates further investigation to understand the impact of COVID-19 on AMR dynamics in these settings.…”